Untested Toxicity Found in Gardasil Vaccine

HPV DNA bound to insoluble aluminum adjuvant.

By NORMA ERICKSON | SANEVAX | OCTOBER 19, 2012

Genetic modification of food has come under severe criticism from the scientific community as new health risks are being discovered. Do genetically modified vaccines carry any less risk? The study below outlines just a few of the unanswered questions about one of the genetically engineered vaccines currently in use, namely Gardasil®.

Dr. Sin Hang Lee of Milford Hospital recently published an article in The Journal of Inorganic Biochemistry entitled, Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil®.

According to Dr. Lee’s research (sponsored by SaneVax Inc.), during the manufacture of Gardasil, Merck may have inadvertently created a new chemical compound composed of HPV L1 gene fragments chemically bound to the aluminum nanoparticles of the AAHS adjuvant used in the vaccine.

If this is true, the toxicity of this chemical has not been tested. No one knows what the potential health consequences the injection of this ‘ingredient’ may be.

Consider some key points extracted from the article by Dr. Lee:

A total of 16 samples of Gardasil® received from Australia, Bulgaria, France, India, New Zealand, Poland, Russia, Spain and the United States were found to contain fragments of HPV-18-L1 gene DNA which was readily detected in 15 of 16 samples tested, or HPV-11-L1 gene DNA, or a mixture of both. After submission of the manuscript, HPV-16-L1 gene fragments were also detected among these samples by a special protocol, Dr. Lee noted in his report.

Dr. Lee stated:

“Although the U.S. Food and Drug Administration recently announced that Gardasil® indeed does contain recombinant HPV L1-specific DNA fragments, the physical condition(s) of these HPV DNA fragments in the final vaccine product has not been characterized.”

Dr. Lee presented experimental evidence to assert that the binding mechanism between the HPV L1 gene DNA and the amorphous aluminum hydroxyphosphate sulfate (AAHS) nanoparticles in Gardasil® is of a chemical nature through ligand exchange of phosphate for hydroxyl, independent of the electrostatic forces. When aluminum (Al3+) and DNA interact, the binding site for Al3+ on the DNA chains is the phosphate groups on the DNA backbones.

For the average medical consumer, if the bond between the DNA and aluminum were electrostatic, it would be much like when you rub a balloon against your head until the static electricity builds up to the point where you can stick the balloon to a wall. As you may have noticed, given a short period of time, the balloon loses the static electric charge and falls off the wall. This is much the same as a vaccine in which the bond between the antigen and adjuvant is electrostatic. Once the vaccine is injected, the recipient’s normal pH level reduces the electrostatic attraction making the antigen and adjuvant separate from each other.

On the other hand, if the bond between the DNA and aluminum is chemical, it is more like taking a blob of super-glue and sticking the balloon to the wall. In this instance, no one knows how long the bond will remain intact.

In light of this substantial difference, Dr. Lee concluded:

“The short-term and long-term impact of the residual fragments of HPV L1 gene DNA, or plasmid DNA, if chemically bound to the mineral aluminum of AAHS nanoparticles is largely unknown and warrants further investigation.”

In Sept 2011, the SaneVax Team informed the FDA that HPV DNA fragments had been found firmly attached to the aluminum adjuvant in 100% of Gardasil samples tested by Dr. Sin Hang Lee of Milford Hospital.

The FDA response included the following statement with no references to back it up:

“Recombinant technology has been used for many years to manufacture medicinal products. Gardasil does contain HPV L1-specific DNA fragments. This is expected, since DNA encoding the HPV L1 gene is used in the vaccine manufacturing process to produce the virus-like particles. The presence of these expected DNA fragments, which are inevitable in vaccine production, is not a risk to vaccine recipients, is not harmful, and this DNA is not a contaminant.”

As you can clearly see, there is no mention whatsoever is made about these fragments possibly being firmly attached to the aluminum adjuvant. The SaneVax Team as well as many eminent scientists and medical professionals around the world believe this ‘tiny’ detail should not be ignored.

If this ‘ingredient’ is indeed an ‘inevitable’ component of recombinant technology, medical consumers have a right to know when, for how long and under what circumstances it was tested for safety.

After an entire year of multiple communication attempts receiving no scientific documentation from the FDA that this ‘ingredient’ did not pose a health threat, the SaneVax Team sent another letter to the FDA Commissioner with one simple request.

This letter asked for copies of documents from the FDA showing:

1)    The date when the FDA and the manufacturer first knew small quantities of residual recombinant HPV L1-specific DNA fragments remain in the vaccine.

2)    The physical condition of the HPV- L1-specific DNA fragments in the Gardasil® vaccine.

To date, the FDA has made no effort to respond to this request. Do they have any documentation? If so, why do they not provide this critical information to medical consumers?

Surely, considering the fact that these fragments are an ‘inevitable’ component of recombinant technology, they have requested safety studies to determine any potential health impact. After all, they are responsible for the health and safety of medical consumers – aren’t they?

One more critical point:

Why did Merck not detect the residues of HPV-18-L1 gene DNA during the production of Gardasil®?

Dr. Lee offered the following explanation:

“…all HPV-18 isolates can be classified into 3 subtypes based on alignments of the DNA sequences of the variants, (i.e. the European, the Asian-American and the African subtypes). In Europe, it has been reported that all of the HPV-18 isolates from patients are found to be of the European or Asian-American variants. In the U.S., 91% of the HPV-18 isolates from white women are reported to be of the European and Asian-American variants, and 64% of the HPV isolates from African American women belong to the African variant.

Since the prevalence of the African variants of HPV-18 among European patients is negligible, the Dutch researchers who originally developed the HPV INNO-LIPA kit naturally selected an HPV-18 probe targeting a homologous sequence shared by all European and Asian-American HPV-18 variants for the testing.

However, the HPV-18 L1 protein-coding gene chosen by the manufacturer for Gardasil® closely related to an African subtype. Failure to detect a target sequence of an African variant HPV-18 DNA in the vaccine Gardasil® with a hybridization probe specifically designed for the European and Asian-American DNA variants may simply reflect the diversity of the L1 protein amino acid sequences within the genotype of HPV-18.”

For medical consumers, this brings additional questions. Has Gardasil® been tested for efficacy against all three HPV-18 variants?

Are families in the United States and Europe putting their children at risk of unknown health consequences resulting from the injection of a new chemical with untested toxicity in order to obtain ‘protection’ against only one type of oncogenic HPV?

The time has come for medical consumers to hold their national health ‘authorities’ accountable. These questions must be answered before any more children become ‘one less.’

(Note: Dr. Lee’s study was commissioned and sponsored by SaneVax Inc. for a future payment not to exceed one U.S. dollar.)

Merck’s Profits Explode as Government-Backed HPV Shot Gardasil Sales Skyrocket

Anthony Gucciardi
NaturalSociety
November 1, 2011

Mega drug manufacturer Merck & Co. is reporting a major increase in third-quarter profits due in part to the skyrocketing sales of death-linked HPV shot Gardasil – up 41 percent to $445 million thanks to government backing and a hugely successful yet deceptive ad campaigns targeted at unsuspecting parents and children. The overall value of Merck shares rose 80 cents, or 2.3 percent, to $35.11. The numbers are up from a year ago, when the company was hit with huge acquisition and legal charges. Of course behind  the monetary surge in Gardasil sales is the horribly corrupt marketing and political techniques used to boost Merck out of economic downfall.

When it comes to Gardasil, Merck is more concerned about pushing the shot on children and generating a profit than examining the true effects of the shot.

 Merck pushes Gardasil on children through omission of facts, political bribery, and blatant lies

How could Merck sell Gardasil in such high quantities despite documentation linking it to  3,589 harmful reactions and 16 deaths between May 2009 and September 2010 alone? Well, Merck likes to pretend that the death link does not exist. Furthermore, Merck uses monetary incentive, also considered bribery, to ensure that Gardasil legislation is swiftly passed by key legislators. Because when it comes to generating profit, Merck has no concern for the health of the individual — especially the target demographic of boys and girls between the ages of 11 and 12.

In order to push Gardasil as a “safe” vaccine, Merck will go as far as to blatantly lie about the side effects of the HPV shot in magazine ads, website banner ads, and even on the official Gardasil website. In my special report on Gardasil ads, I documented how Merck supplements the real known side effects of Gardasil such as death and Guillain-Barre Syndrome for less threatening ones such as headache and nausea.

As for political bribery, Merck has been caught by Cal Watchdog supplying key California legislators with thousands of dollars. Of course these key legislators were instrumental in the passing of the Gardasil bill that now allows for 12 year old children to decide whether or not they would like to be injected with the Gardasil vaccine without any parental consent. Given deceptive information about the HPV shot Gardasil, it is reasonable to believe that these young children would consider the shot to be relatively harmless. Unfortunately, those who do not follow health news are oftentimes in the dark over Gardasil dangers.

The dangers of Gardasil are so extensive that a timeline has been made documenting just the past several months in developments. As more information continues to come out, Merck may soon see a significant decrease in Gardasil profits.

Why Use the Human Papillomavirus Vaccine?

By Luis R. Miranda
The Real Agenda
September 2, 2011

According to the Food and Drug Administration (FDA), the Human Papillomavirus does not cause cervical cancer. This leads me to think and ask, why a woman would be injected with the vaccine that supposedly fights the HPV? Also, why a mother or responsible person would let his 9 year old daughter to be injected with this vaccine?

In Mexico health authorities plan to inject the HPV vaccine on all the girls from next year on, said the Health  Minister on Tuesday.

Beginning in 2012, the HPV vaccine will be included in the cocktail of injections administered to all girls age 9 and above, said Health Minister Jose Angel Cordova.

Ironically, the minister revealed that deaths from cervical cancer have declined by 47 percent in Mexico over the past two decades. This is a significant number. So why do they want to vaccinate children” Well, according to Cordova, there were still 13.4 cases per 100,000 women last year.

The decision to inject indiscriminately all children is viewed with confusion due to the fact that the virus does not cause cervical cancer and on top of this it is eliminated naturally by the body with the help of good nutrition and a healthy immune system. But Mexican authorities want to make the HPV vaccine universal, according to them, to reduce mortality from this cancer by 50 percent in women over 25 years of age.

HPV is sexually transmitted and often the body can eliminate it by itself without the aid of vaccines or pharmaceuticals, cites a report by Agence France Press. However, in some cases the infection remains and can eventually lead to cervical cancer.

Strains 16 and 18 represent 70 percent of cervical cancer cases worldwide, which number about 500,000 a year, according to the Fund for Population Activities (UNFPA).

Although these numbers seem alarming, and they should be for those who become could potentially become ill with cervical cancer, the American Medical Association (AMA) says: “There is significant evidence to indicate that there is no benefit from the vaccine. The disappearance of the virus during periods of 12 months is not related to the use of the vaccine. It is unlikely that vaccination has any significant benefit.”

Why then Mexico or any other country would use the HPV vaccine and would seek to injected on all girls and women? The fact that the virus does not cause cervical cancer and the vaccine is ineffective in treating it needs to be added to another finding: the vaccine only protects against two or three strains from a total of more than 100. All this without counting the more than 3500 serious side effects that the vaccine has been shown to cause in many patients who have been injected.

Persistent infection with HPV, not the human papillomavirus itself, is what promotes or causes precancerous lesions and cancer. But if the vaccine does not treat or eliminate the virus, what good does it do? On the other hand, according to the FDA, the HPV vaccine in women who have human papillomavirus increases the risk of cervical cancer by 44.6%, because this vaccine promotes the development of precancerous lesions in the uterus, which eventually leads to cervical cancer.

The falsity of the effectiveness of the vaccine to prevent cancer should be added to the fact that medical practices used today to assess cervical health do not examine whether a woman has cervical cancer. The exams only test for the presence of the HPV. Finally, we must say that most infections are short lived and are not associated with cervical cancer.

What is the solution to remove the two or three strains of human papillomavirus if the vaccines are ineffective? As in most other cases related to the prevention of infections in humans, a healthy immune system is always able to destroy viruses and bacteria that can eventually trigger infections. How do you get a healthy and strong immune system? Through the consumption of foods that are not processed, gluten-free, with no MSG’s or other  preservatives that are added to foods to keep them for long. These substances prevent the absorption of the nutrients the body needs. It is necessary to avoid eating genetically modified organisms (GMO), which also cause disturbances in our body because of its artificial and manipulated content.

Contrary to what many main stream media would have us believe, there is no pill or pharmaceutical product for every health problem. In fact, drugs are usually the cause of the illnesses suffered by most people because of their side effects. No matter how fashionable and trendy the media say it is to be vaccinated with Gardasil or Cervarix; the reality falls far short of their claims.

Por que usar a Vacina contra Vírus do Papiloma Humano?

Por Luis R. Miranda
The Real Agenda
01 de setembro de 2011

De acordo com a Food and Drug Administration (FDA) dos Estados Unidos, o vírus do Papiloma Humano não causa câncer cervical. Isso me leva a pensar e perguntar, por que uma mulher escolheria ser injetada com a vacina que supostamente combate o vírus do papiloma humano? E também, por que uma mãe ou pessoa responsável deixaria sua filha de 9 anos ser injetada com esta vacina?

No entanto, México planeja injetar a vacina do papiloma humano (HPV), em todas as meninas a partir do próximo ano, disse o ministério de saúde do país na terça-feira.

No início de 2012, a vacina contra o HPV será incluída no coquetel de injeções administradas a todas as meninas na idade de 9 anos, disse o ministro da Saúde José Angel Cordova.

Ao mesmo tempo, o ministro revelou que as mortes por câncer cervical diminuíram em 47 por cento no México durante as últimas duas décadas um número significativo, mas ainda apareceram 13,4 casos por cada 100.000 mulheres no ano passado.

A decisão de injetar de forma indiscriminada a todas as crianças é vista com confusão devido ao fato de que o vírus não causa câncer cervical, mas é eliminado naturalmente pelo corpo com a ajuda de uma boa alimentação e um sistema imunológico saudável. Mas as autoridades mexicanas querem fazer a vacina contra o HPV universal, de acordo com eles para reduzir a mortalidade por esse câncer em 50 por cento em mulheres acima de 25 anos.

HPV é sexualmente transmissível e o corpo pode eliminá-lo por si mesmo sem a ajuda de vacinas ou de produtos farmacêuticos, cita um relatório da Agence France Press. No entanto, em alguns casos, a infecção permanece e pode levar ao câncer cervical.

Cepas 16 e 18 representam 70 por cento dos casos de câncer cervical em todo o mundo, para um total de 500.000 casos por ano, segundo o Fundo para a População (UNFPA).

Embora estes números parecem alarmantes, e são para aquelas que ficam doentes com câncer cervical, a Associação Médica Americana (AMA) diz: “Não há evidências significativas para indicar qualquer benefício do uso da vacina. O desaparecimento do vírus durante períodos de 12 meses não está relacionado com o uso da vacina. É improvável que a vacinação tenha qualquer benefício significativo. “

Por que então o México ou qualquer outro país faria a vacina contra o HPV universal e tentaria injetar suas crianças e mulheres jovens? Os fatos de que o vírus não causa câncer cervical e que a vacina é ineficaz no tratamento, devem ser adicionados ao fato que a vacina protege apenas contra dois ou três cepas de um total de mais de 100. Tudo isso sem contar os mais de 3500 efeitos colaterais sérios que a vacina causa em pacientes que têm sido injetadas.

E a infecção persistente com HPV, e não o vírus do papiloma humano em si, é o que promove ou causa lesões pré-cancerosas e câncer. Mas se a vacina não trata ou elimina o vírus, qual é o objetivo da vacina? Por outro lado, segundo a FDA, a vacina contra o HPV em mulheres que têm o papilomavírus humano aumenta o risco de câncer cervical em 44,6%, porque esta vacina promove o desenvolvimento de lesões pré-cancerosas no útero, que eventualmente levam ao câncer cervical.

A falsidade da eficácia da vacina para prevenir o câncer deve ser acrescentado a que as práticas médicas utilizadas hoje para avaliar a saúde do útero não examina se uma mulher tem câncer cervical, mas somente se ela tem o vírus HPV. Finalmente, devemos dizer que a maioria das infecções no útero são de curta duração e não associadas ao câncer cervical.

Qual é a solução para remover prevenir as duas ou três cepas do papilomavírus humano? Como na maioria dos outros casos relacionados com a prevenção de infecções em seres humanos, um sistema imunológico saudável é sempre capaz de destruir vírus e bactérias que podem eventualmente levar a infecções. Como podemos ter um sistema imunológico saudável? Através de um plano de alimentação composto de alimentos que não são processados, glúten, MSG, conservantes adicionados aos alimentos processados ​​para preservá-los por muito tempo. Essas substâncias impedem a absorção dos nutrientes que o corpo necessita. É necessário evitar o consumo de produtos geneticamente modificados (GM), que também causam distúrbios em nosso corpo pelo seu conteúdo artificial e manipulado.

Ao contrário do que a mídia querem nos fazer crer, não há uma pílula ou remédio farmacêutico para cada problema de saúde. Na verdade, as drogas são geralmente a causa das doenças sofridas pela maioria das pessoas por causa de seus efeitos colaterais. Não importa quanto os meios de comunicação digam que é moda se vacinar com Gardasil ou Cervarix, a realidade fica muito além das sua propaganda.

Mexico to give HPV vaccine to all girls ages 9 and older

AFP
August 31, 2011

MEXICO CITY — Mexico plans to administer the vaccine against human papillomavirus (HPV), which can cause cervical cancer, to all girls beginning next year, the country’s health ministry said Tuesday.

Beginning in 2012, the HPV vaccine will be part of the normal course of shots given to all girls at the age of nine, Health Minister Jose Angel Cordova said.

Cervical cancer kills about 4,200 women in Mexico each year.

The minister said while deaths from cervical cancer had fallen 47 percent in the country over the past two decades, there was still 13.4 cases for every 100,000 women last year.

Mexican health authorities hope that by making the HPV vaccine universal, they can cut the mortality rate from this type of cancer by 50 percent for women over the age of 25.

HPV is sexually transmitted and most of the time the body can clear it on its own. However, in some cases the infection remains and can eventually lead to cervical cancer.

HPV types 16 and 18 account for 70 percent of cervical cancer cases worldwide, which number about 500,000 per year, according to the UN Population Fund (UNFPA).

Related Links:

Togel178

Pedetogel

Sabatoto

Togel279

Togel158

Colok178

Novaslot88

Lain-Lain

Partner Links